Dr. Paul Dato, Director of Unio’s Cancer Center of Excellence, Shares his Insights on Darolutamide in Prostate Cancer Management

Dr. Paul Dato, MD

We are proud to announce that Dr. Paul Dato, MD, Director at Unio’s Cancer Center of Excellence, has been invited to share his insights as a Urologist, together with Dr. Rana McKay from UCSD, on the use of Darolutamide for managing metastatic hormone-sensitive prostate cancer. Please click here or on the image below to view the video and read the full article.